Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05629377 · ClinicalTrials.gov registry record

Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)

A clinical trial of Hypothalamic Amenorrhea, sponsored by Mayo Clinic.

Recruiting
Registry status
90
Enrollment target
1
Study location

NCT05629377 is a study of Hypothalamic Amenorrhea that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05629377, a study of Hypothalamic Amenorrhea, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

Hypothalamic amenorrhea (HA) occurs during reproductive years and results in stopped menstrual cycles and infertility which can be prolonged from months to years and is characterized by varying combinations of psychosocial stress, anxiety, high levels of physical activity, and/or weight loss. Data from our group indicates that one-third of women with HA (mean age: 27 yrs) have preclinical cardiovascular disease (CVD) measured noninvasively as vascular dysfunction and vascular inflammation. This study will use HA as a marker of fertility status for cardiovascular health and perform dense-phenotyping using remote patient monitoring (FitBit) and patient reported outcomes (questionnaires) to determine which HA phenotypes are related to preclinical CVD and inflammation.

Conditions Studied

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-01-17
Est. Completion 2026-05

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05629377

The ClinicalTrials.gov registry entry for NCT05629377 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypothalamic Amenorrhea appearing as the primary indexed condition, and to 0 interventions.

NCT05629377 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05629377 about?

NCT05629377 is a clinical study titled "Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)". Hypothalamic amenorrhea (HA) occurs during reproductive years and results in stopped menstrual cycles and infertility which can be prolonged from months to years and is characterized by varying combinations of psychosocial stress, anxiety, high levels of physical activity, and/or weight loss. Data f...

What is the current status of trial NCT05629377?

This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2023-01-17. Estimated completion is 2026-05.

What conditions does trial NCT05629377 study?

This clinical trial studies the following conditions: Hypothalamic Amenorrhea.

Who is sponsoring clinical trial NCT05629377?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05629377 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypothalamic Amenorrhea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.